Castle Creek Biosciences

Exton, PA · Founded 2015 · Privately Held (backing)

Developer of a fibroblast based therepy designed to treat rare and serious genetic diseases. Castle Creek Biosciences is based in Exton, PA and was founded in 2015. It has raised $419 million across 4 recorded rounds; the latest was a $75 million later-stage round in Feb 2025.

PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$419.4M
Last round
Later Stage VC
Feb 2025
Cap table — not yet on record

Castle Creek Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Pro
The prices on Castle Creek Biosciences
  • ·57 fund marks: filer, period, implied $/share
Pro · $99 a month
List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Frequently asked about Castle Creek Biosciences

Where does Castle Creek Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Castle Creek Biosciences's 4 recorded funding rounds.